Home › Funds › Foyston, Gordon & Payne Inc › IQV
Foyston, Gordon & Payne Inc position in IQV
IQVIA HLDGS INC · Health Care
Foyston, Gordon & Payne Inc reported holding 19,476 shares of IQV (IQVIA HLDGS INC) in its Q3 2026 13F filing — a position valued at US$5.2M, representing 1.05% of its reported portfolio and ranking #34 among its reported holdings. Foyston, Gordon & Payne Inc has disclosed IQV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Foyston, Gordon & Payne Inc's IQV position evolved
Foyston, Gordon & Payne Inc first disclosed a stake in IQV in Q4 2025 at 26,138 shares (US$5.9M). Across 4 filings, Foyston, Gordon & Payne Inc increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 19,476 shares valued at US$5.2M — a reduction of -9,336 shares quarter over quarter.. Notable position changes include a 32% trim in Q3 2026 (shares fell 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 26.14K | $5.89M | New |
| Q1 2026 | 29.96K | $5.11M | Add |
| Q2 2026 | 28.81K | $5.63M | Reduce |
| Q3 2026 | 19.48K | $5.24M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IQV and 13F data
IQV (IQVIA HLDGS INC) is a Health Care company. 25 other funds we track also report a position in IQV — the largest reported positions include Harris Associates (Oakmark) (US$2.35B), HARRIS ASSOCIATES L P (US$2.35B), Boston Partners (US$1.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IQV
- Harris Associates (Oakmark) 12.18M sh · $2.35B · Q2 2026
- HARRIS ASSOCIATES L P 12.18M sh · $2.35B · Q2 2026
- Boston Partners 4.37M sh · $1.17B · Q3 2026
- Artisan Partners Limited Partnership 3.46M sh · $930.59M · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 2.67M sh · $717.70M · Q3 2026
- LYRICAL ASSET MANAGEMENT LP 1.25M sh · $337.08M · Q3 2026
More on Foyston, Gordon & Payne Inc
FAQ
How long has Foyston, Gordon & Payne Inc held IQV?
Foyston, Gordon & Payne Inc has disclosed IQV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Foyston, Gordon & Payne Inc's current position in IQV?
As of Q3 2026, Foyston, Gordon & Payne Inc holds 19.48K shares of IQV (IQVIA HLDGS INC), valued at $5.24M, representing 1.05% of its reported portfolio and ranking #34.
Has Foyston, Gordon & Payne Inc been buying or selling IQV?
In the latest 13F filing (Q3 2026), Foyston, Gordon & Payne Inc reduced its position in IQV.
Which other funds hold IQV?
Other major institutional holders of IQV include Harris Associates (Oakmark), HARRIS ASSOCIATES L P, Boston Partners, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.